Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Trial Investigating the Cardiovascular Effects of Agomelatine and Escitalopram in Patients With Major Depressive Disorder.

NCT01483053 is registered in ClinicalTrials.gov with Baker Heart and Diabetes Institute as lead sponsor.

NCT NCT01483053
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01483053 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Trial Investigating the Cardiovascular Effects of Agomelatine and Escitalopram in Patients With Major Depressive Disorder.
Lead sponsor
Baker Heart and Diabetes Institute
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2014
Completion date
February 28, 2015
Enrollment
40 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder (mdd)